IDEBENONE    (pronounced:  eye deb' eh known)
Order  Idebenone    45mg           www.idebenone.info 45 mg 60 caps $23.99
Order  Idebenone    45mg 45 mg 4 bottles @ $20.00
Order  Idebenone    45mg 45 mg 12 bottles @ $15.00
Order  Idebenone  150mg 150 mg 30 caps $34.99
Order  Idebenone  150mg           4 boxes @ $34 = $120 150 mg 4 boxes @ $30.00
Order  Idebenone  150mg         12 boxes @ $28 = $300 150 mg 12 boxes @ $25.00



  • Research 
                                         www.idebenone.org

    Weyer G, Babeji-Dolle RM, Hadler D, Hofmann S, Herrmann WM, "A controlled study of 2 doses of idebenone in the treatment of Alzheimer's disease." Neuropsychobiology 1997; 36(2):73-82  

    Ranen NG and colleagues, "A controlled trial of idebenone in Huntington's disease" Mov Disord 1996 Sep; 11(5):549-554  

    Ikejiri Y, Mori E, Ishii K, Yasuda M, Sasaki M, "Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS" Neurology 1996; Aug 47(2); 583-585. 

    Pisano P and colleagues, "Plasma concentrations and pharmacokinetics of idebenone and its metabolites following single and repeated doses in young patients with mitochondrial encephalomyopathy." Eur J Pharmacol 1996; 51(2):167-169.  

    Gillis JC, Benefield P, McTavish D, "Idebenone, a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders." Drugs Aging 1994; Aug;5 (2): 133-152.  

    Bergamasco B, Scarzella L,  "Idebenone, a new drug in the treatment of cognitive impariment in patients with dementia of the Alzheimer type." Funct Neurol 1994; May;9(3):161-168. 

    Nitta A, Hasegawa T,  "Oral administration of idebenone, a stimulator of NGF synthesis recovers reduced NGF content in aged rat brain." Neuosci Lett 1993 Dec 12; 163(2):219-222.  

    Suno M, Nagaoka A, "Inhibition of brain mitochondrial swelling by idebenone." Arch Gerontol Geriatr 1989 May; 8(3):299-305. 

    Ihara Y, Namba S, Shiraba T, "Mitochondrial encephalomyopathy (MELAS), pathological study and successful therapy with coenzyme Q10 and idebenone." J Neurol Sci 1989 May; 90(3):263-271.

    Lerman-Sagie T, Rustin P, Lev D, "Dramatic improvement in mitochondrial cardiomyopathy following treatment with idebenone." J Inherit Metab Dis 2001 Feb;24(1):28-34.

    Gutzmann H, Hadler D., "Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study." J Neural Transm Suppl 1998;54:301-10.

    Yamada K, Nitta A, Hasegawa T, "Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease." Behav Brain Res 1997 Feb;83(1-2):117-22.

    Bergamasco B, Scarzella L, "Idebenone, a new drug in the treatment of cognitive impairment in patients with dementia of the Alzheimer type."  Funct Neurol 1994
    May-Jun;9(3):161-8.